The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
Open accessPublished version of a preprint
Abstract
Metastasis to distant tissues is the chief driver of breast cancer–related mortality, but little is known about the systemic physiologic dynamics that regulate this process. To investigate the role of neuroendocrine activation in cancer progression, we used in vivo bioluminescence imaging to track the development of metastasis in an orthotopic mouse model of breast cancer. Stress-induced neuroendocrine activation had a negligible effect on growth of the primary tumor but induced a 30-fold increase in metastasis to distant tissues including the lymph nodes and lung. These effects were mediated by β-adrenergic signaling, which increased the infiltration of CD11b+F4/80+ macrophages into primary tumor parenchyma and thereby induced a prometastatic gene expression signature accompanied by indications of M2 macrophage differentiation. Pharmacologic activation of β-adrenergic signaling induced similar effects, and treatment of stressed animals with the β-antagonist propranolol reversed the stress-induced macrophage infiltration and inhibited tumor spread to distant tissues. The effects of stress on distant metastasis were also inhibited by in vivo macrophage suppression using the CSF-1 receptor kinase inhibitor GW2580. These findings identify activation of the sympathetic nervous system as a novel neural regulator of breast cancer metastasis and suggest new strategies for antimetastatic therapies that target the β-adrenergic induction of prometastatic gene expression in primary breast cancers. Cancer Res; 70(18); 7042–52. ©2010 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the context of metastatic breast cancer, for example, stress effects on tumor metastasis are mediated by β-adrenergic up-regulation of monocytes and macrophages within the tumor microenvironment [44] (i.e., the same dynamic that drives the CTRA transcriptome shift in circulating blood [9]).”
From Human Social Genomics (2014) · cites this paper as [44]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, Sloan et al. found that both stress-induced and pharmacological β-adrenergic stimulation promoted macrophage migration into tumor tissue in a mouse model of breast cancer. These macrophages then adopted an immunosuppressive M2 phenotype, leading to increased production of TGF-β, VEGF, and MMP-9, which in turn promoted angiogenesis and metastasis.322”
From Drug repurposing for cancer therapy (2024) · cites this paper as [322]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [20]
In the citing paper
“Parallel effects have been observed in experimental animal models of cancer, and those analyses again identify a prominent role for SNS activation of β-adrenergic signaling [43], [44].”
From Human Social Genomics (2014) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,414
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,827
DeNardo, D. G., Barreto, J., Andreu, P., Vásquez, L. J., Tawfik, D., Kolhatkar, N. S., & Coussens, L. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.018 · Cited by 1,395
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Self-citationDo stress-related psychosocial factors contribute to cancer incidence and survival?
Chida, Y., Hamer, M., Wardle, J., & Steptoe, A. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1134 · Cited by 1,072
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationSocial networks, social support, and survival after breast cancer diagnosis
Kroenke, C. H., Kubzansky, L. D., Schernhammer, E. S., Holmes, M. D., & Kawachi, I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2846 · Cited by 792
Catecholamine Influences and Sympathetic Neural Modulation of Immune Responsiveness
Madden, K. S., Sanders, V. M., & Felten, D. L. (1995) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.002221 · Cited by 441
Cited by
Sorted by citations
Items 901–928 of 928
Nanomedicine for targeting crosstalk between nerves and cancer
Yu, X., Xiang, G., Wang, H., Li, X., Huang, H., Song, S., Xi, Q., Zhao, J., & Liu, F. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115269
Cheng, S., Hua, Y., Liao, Q., & Liu, Q. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189687
Jain, D., Pandey, N., Jha, S. K., Sinha, S., Singh, R., Alam, J., Aggarwal, B., Chauhan, N., Acharya, A., Anu, P. V., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102994 · Cited by 1
“9,14,15 This adrenergic signaling also impairs CD8 + T cell function and promotes infiltration of tumor-associated (legend continued on next page) macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs).”
Aneni, E. C., Pena, C. J., Ahmed, O., & Otite, F. O. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045805
“23–25 These same mechanisms are proposed to lead to CVD in people with OSA.”
Zhen, H., Wang, C., Wang, X., Huang, H., Li, J., & Zhao, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1852495
“At the T cell level, sustained b -AR signaling directly drives exhaustion of CD8 + T cells, which is characterized by increased expression of inhibitory receptors including PD-1 and TIM-3 together with reduced production of effector cytokines like IFN-g (44).”
Neuronal regulation of cancer: Mechanisms, functional consequences and therapeutic opportunities
Liu, S., Cao, C., Zhu, C., Gui, L., & Wu, P. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189693
Satilmis, H., Verheye, E., Faict, S., Heestermans, R., Becker, A. D., Vanderkerken, K., Bruyne, E. D., Menu, E., Sloan, E. K., & Veirman, K. D. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218802
Self-citationAntitumour Effects of β-Blockers: A Narrative Review of the Literature
Melissaridou, D., Savvidou, O. D., Lianou, I., Kaspiris, A., Korkolopoulou, P. A., Papadimitriou, Ε., & Papagelopoulos, P. J. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48090865
“These immunomodulatory effects may partly explain the growing interest in combining β -blockers with immune checkpoint inhibitors and other immunotherapeutic strategies [12,15].”
Ma, C., Ma, C., Xing, X., Sun, C., Guan, L., Schiöth, H. B., & Liu, W. (2026) · 癌症：英文版 · doi:10.34133/cancomm.0053
“Although systemic β -blockers act on both tumor and stromal compartments and therefore cannot fully disentangle cell-type-specific targets, the overall evidence supports SNS/ β -adrenergic output as a druggable axis linking chronic stress to metastatic spread [ 84 , 87 , 88 ].”
InfluentialCancer Neuroscience: From Local Neuro–Immune Microenvironments to Systemic Brain–Body Circuitry
Xie, M., Zhao, Y., Xing, X., Liu, Y., Zhao, J., Yao, M., Tang, J., & Zhao, J. (2026) · MedComm · doi:10.1002/mco2.71025
“Chronic stress has been known to lead to about 30 times more lung metastasis in breast cancer models [ 81 ].”
Ibrahim, M. S., Elsayyad, N. M. E., & Noshi, S. H. (2026) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2026.2738747
“…b -adrenergic blockade has been shown to attenuate stress-associated metastatic dissemination, while more recent studies demonstrated that propranolol inhibits epithelial-to-mesenchymal transition (EMT), migration, and invasion in breast cancer models [ (Sloan et al. 2010; Zheng et al. 2024)].”
Priyanka, H. P., Pratap, U. P., Nair, R. S., Ponnan, S. M., Vasantharekha, R., Hannah, L. E., & ThyagaRajan, S. (2026) · Medical Oncology · doi:10.1007/s12032-026-03408-1
Research Progress on the Application of Antidepressants in Breast Cancer Treatment
Niu, Z., Wang, Y., Li, M., & 李玉成 (2026) · Chinese medicine and natural products · doi:10.1055/a-2943-5227
Rubio-Casillas, A., Redwan, E., Genova, S. N., & Uversky, V. (2026) · Applied microbiology · doi:10.3390/applmicrobiol6100117
Patrad, E., & Alizadeh, A. M. (2026) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2026.105083
Neuro-immune interactions in tumors, immune-related disorders, and infections
Zhuang, Q.-Y., Zhang, S.-W., Shao, Z., Xiao, Y., & Jiang, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02842-x
Neuron activity-dependent cancer progression
Nelson, J., Ahmad, K. A., Pan, Y., & Taylor, K. R. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag214
Tudoraşcu, D. R., Vere, C. C., Petrescu, M., Ciurea, A.-M., Pana, R. C., Dan, A. O., Târtea, E. A., Greșiță, A., Hădăreanu, D.-R., Obleagă, C. V., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209090
Xia, N., Huang, R., Zhong, H., Zhou, Z., Wang, S., Wang, Z., & Shen, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1890810
“…tumor-cell invasion, angiogenesis, myeloid-cell accumulation, and impaired antitumor T-cell activity, whereas pharmacological b -blockade can partially reverse several of these effects (20, 21, 23 – 25 , 92 Early prospective studies have primarily demonstrated pharmacodynamic and biomarker effects.”
Zhao, P.-Y., Rozpędek‐Kamińska, W., Chen, Z., & Jin, W. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101492
Chen, Y., & Tang, D. (2026) · International Journal of Cancer · doi:10.1002/ijc.70681
Zhang, Y., Ye, Z., Wang, Y., Tang, S., & Chen, G. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.08.008
Schizas, N., Thurfjell, V., Yu, H., Mezheyeuski, A., Ferreira, I. M., Micke, P., Rask, G., Wärnberg, F., Strell, C., & Schiza, A. (2026) · Research Square · doi:10.21203/rs.3.rs-11063194/v1
BindingDB Entry 50002739: Design and synthesis of aryloxypropanolamine as β
BindingDB (2020) · UC San Diego · doi:10.7270/q2dv1njc
Lin, G., & Luo, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1899935
Targeting the Immune System for Cancer Therapy: Lessons for Perioperative Management?
Koirala, R. S., & Gyorki, D. E. (2015) · Current anesthesiology reports · doi:10.1007/s40140-015-0111-z
Environmental Manipulation and Neuropeptide Effects on Energy Balance and Cancer
Cao, L. (2015) · Energy balance and cancer · doi:10.1007/978-3-319-16733-6_2
Metadata
- Authors
- Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., Arevalo, J. M. G., Morizono, K., Karanikolas, B. D. W., Wu, L., Sood, A. K., & Cole, S. W.
- Affiliations
- University of California, Los Angeles (US)
- Authors' Affiliations: 1UCLA Norman Cousins Center at the Semel Institute for Neuroscience and Human Behavior, Department of Medicine, 2Division of Hematology-Oncology, UCLA School of Medicine, UCLA AIDS Institute, 3Jonsson Comprehensive Cancer Center, 4UCLA Department of Molecular and Medical Pharmacology, and 5UCLA Molecular Biology Institute, Los Angeles, California; and 6Departments of Gynecologic Oncology and Cancer Biology, M.D. Anderson Comprehensive Cancer Center, Houston, Texas
- Corresponding author
- Sloan, Erica K.
- ORCID
- Venue
- Cancer Research
- Published
- 2010-09-14
- Volume
- 70
- Issue
- 18
- Pages
- 7042-7052
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2940980
- OpenAlex
- W2107567947
- Cited by
- 930
- References
- 53
- Citations by year
- 2026: 97 · 2025: 76 · 2024: 72 · 2023: 63 · 2022: 78 · 2021: 94 · 2020: 59 · 2019: 65 · 2018: 42 · 2017: 40 · 2016: 45 · 2015: 50 · 2014: 38 · 2013: 49 · 2012: 32
- FWCI
- 23.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA 109298, R01CA110793, CA 110793, R01CA109298, R01CA116778, CA-116778, R21CA138687, CA138687, R01CA160890)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- breast cancer metastasis, sympathetic nervous system, neuroendocrine activation, stress, beta-adrenergic signaling, tumor-associated macrophages, M2 macrophage polarization, propranolol, GW2580, lymph node metastasis, lung metastasis, orthotopic mouse model, anti-metastatic therapy
- MeSH terms
- Adenocarcinoma, Animals, Female, Macrophages, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Mice, Nude, Neoplasm Metastasis, Stress, Physiological, Sympathetic Nervous System, T-Lymphocytes, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
